Legend Biotech (LEGN) Return on Invested Capital (2021 - 2025)
Historic Return on Invested Capital for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 133.48%.
- Legend Biotech's Return on Invested Capital rose 938000.0% to 133.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 133.48%, marking a year-over-year increase of 938000.0%. This contributed to the annual value of 92.63% for FY2024, which is 216400.0% down from last year.
- Legend Biotech's Return on Invested Capital amounted to 133.48% in Q3 2025, which was up 938000.0% from 131.91% recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Return on Invested Capital ranged from a high of 133.48% in Q3 2025 and a low of 48152.63% during Q2 2021
- Its 5-year average for Return on Invested Capital is 2980.68%, with a median of 16.55% in 2023.
- Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -222200bps in 2021, then soared by 938000bps in 2025.
- Legend Biotech's Return on Invested Capital (Quarter) stood at 21.29% in 2021, then soared by 102bps to 0.45% in 2022, then soared by 7209bps to 32.57% in 2023, then soared by 244bps to 112.01% in 2024, then grew by 19bps to 133.48% in 2025.
- Its last three reported values are 133.48% in Q3 2025, 131.91% for Q2 2025, and 116.42% during Q1 2025.